EQUITY RESEARCH MEMO

Deseret Labs

Generated 5/11/2026

Executive Summary

Conviction (model self-assessment)55/100

Deseret Laboratories, Inc. (DLI) is a full-service custom manufacturer serving the nutraceutical, pharmaceutical, over-the-counter (OTC), and homeopathic industries. Based in Salt Lake City, Utah, and founded in 2017, the company operates state-of-the-art facilities and partners closely with clients to ensure quality, on-time delivery, and value. DLI’s reputation for integrity and solution-minded capabilities has made it a trusted partner for global brands seeking reliable contract manufacturing. The company’s focus on diverse product categories positions it well to serve a broad customer base, though it operates in a competitive outsourcing market.

Upcoming Catalysts (preview)

  • Q4 2026Facility Expansion or New Capability Announcement70% success
  • TBDKey Client Partnership or Long-Term Agreement50% success
  • Q2 2026Regulatory Certification (FDA Inspection Clearance)80% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)